Thymopoiesis depends on the recruitment and expansion of bone marrow-derived progenitor populations; tight regulation of these processes is required for maintenance of the homeostasis of the T lineage. Lyl-1, a transcription factor that regulates hematopoietic progenitors, is expressed in thymocyte progenitors until T cell commitment. Here we demonstrate a requirement for Lyl-1 in lymphoid specification and the maintenance of early T lineage progenitors (ETPs). Lyl-1 deficiency resulted in profound defects in the generation of lymphoid-primed multipotent progenitors (LMPPs), common lymphoid progenitors (CLPs) and ETPs. Lyl-1-deficient ETPs and thymocyte progenitors at the CD4 − CD8 − double-negative 2 (DN2) stage showed more apoptosis, blocked differentiation and impaired population expansion. We identified Gfi1 as a critical transcriptional target of Lyl-1-mediated lymphopoiesis of T cells. Thus, Lyl-1 is a pivotal component of a transcriptional program that controls the lymphoid specification and maintenance of ETPs.
A r t i c l e s
The generation of T cells in the thymus crucially depends on the recruitment and expansion of multipotent bone marrow-derived progenitor populations 1 . Although the specific identity of the thymusseeding progenitor is still a matter of debate, studies have identified extensive T lineage potential in a subset of lymphoid-primed multipotent progenitors (LMPPs) whose hallmark is high expression of the receptor tyrosine kinase Flt3 (refs. 2, 3) . LMPPs are thought to differentiate into ETPs, which represent the earliest and most efficient intrathymic progenitors of T cells. ETPs share fundamental characteristics with bone marrow progenitors, such as high expression of the cell-surface markers c-Kit and CD44, the absence of markers of mature cells and multilineage developmental potential 4 . After arriving in the thymus, ETPs lose the potential to generate B cells, whereas their potential to develop into myeloid cells, natural killer cells and dendritic cells is retained at the next thymocyte developmental stage (CD4 − CD8 − double-negative 2a (DN2a)) 4, 5 . ETPs and DN2 thymocytes undergo population expansion of 1,000-fold (ref. 6) , which leads to development into the DN2b stage, at which point developmental potential is restricted to the T lineage. At the DN3a stage, the proliferation of fully committed T cell progenitors decelerates and the αβ and γδ T cell lineages diverge.
Although much is known about the transcriptional regulation of lineage fate in multipotent progenitor cells [7] [8] [9] [10] [11] , the mechanisms that control and maintain stage-specific progenitors are just beginning to be understood. The distinct transcriptional program observed in thymocyte progenitors at the ETP and DN2 stages suggests sustained regulatory input from a core group of transcription factors associated with hematopoietic stem cells (HSCs), including PU.1, Scl, Mef2c, GATA-2, C/EBP-α and Lyl-1, which all undergo sharp downregulation before the DN3 stage 12 . Such data indicate that the transcriptional circuitry that maintains the function of adult HSCs may also be used to sustain intrinsic control over uncommitted thymic progenitor cells throughout the critical stages of the population expansion of pro-T cells 13 .
Lyl-1 is a basic helix-loop-helix transcription factor critically involved in the homeostasis of immature hematopoietic cells [14] [15] [16] . Although its expression is broad in the hematopoietic system, its expression is highest in bone marrow progenitor cells and pro-B cells but is undetectable in mature T cells [17] [18] [19] . Notably, Lyl1 −/− bone marrow cells selectively fail to engraft any lymphoid lineage after transplantation, which suggests a role for Lyl-1 in early lymphoid differentiation 15, 17 .
LYL1 was originally discovered by its ectopic expression in human t(7;19)(q35;p13)-positive T cell acute lymphoblastic leukemia 20 . However, high LYL1 expression is independent of specific genomic alterations and has high correlation with an immature 'ETP-like' phenotype and genotype and poor prognosis of T cell acute lymphoblastic leukemia 21 . Despite such clinical relevance, the function A r t i c l e s of Lyl-1 in normal and malignant hematopoiesis has remained unknown. Mouse studies have identified weak oncogenic potential for Lyl1 in T cell and B cell lymphomas, but the mechanism of Lyl-1-mediated transformation has remained elusive 16, 22 . In this study, we demonstrate that Lyl-1 was required for the lymphoid specification of multipotent progenitor cells and for the population expansion and survival of ETPs. Collectively our results support a model in which Lyl-1 regulates a transcriptional program needed to control the maintenance of uncommitted T cell progenitors during their population expansion in the thymus.
RESULTS

Generation of LMPPs and ETPs dependent on Lyl1 'dose'
We first assessed Lyl1 expression in purified HSCs (lineagenegative (Lin − ) Sca-1 + c-Kit + (LSK) Flt3 − ), multipotent progenitors (MPPs; LSK Flt3 lo ), LMPPs (LSK Flt3 hi ), ETPs (Lin − c-Kit + CD25 − ), DN2 thymocytes (Lin − c-Kit + CD25 + ) and DN3 thymocytes (Lin − c-Kit − CD25 + ) by quantitative real-time PCR. The multipotent bone marrow progenitor populations MPPs and LMPPs, as well as ETPs, had high expression of Lyl1. In contrast, HSCs and DN2 thymocytes had 30% as much expression of Lyl1 as MPPs, LMPPs and ETPs had, whereas Lyl1 transcripts were undetectable in DN3 cells committed to the T lineage (Fig. 1a) . We next quantified the bone marrow HSC, MPP and LMPP populations in wild-type, Lyl1 +/− and Lyl1 −/− mice. Lyl1 +/− and Lyl1 −/− mice had a lower frequency and total number of bone marrow LSK cells than did wild-type mice. However, detailed analysis showed only a slightly lower frequency and total number of HSCs (77% as much) in these mice and no significant difference between mice in the frequency or number of MPPs. In contrast, we found a much lower frequency and absolute number of LMPPs in Lyl1 −/− mice than in wild-type mice (26% as much; Fig. 1b-d) , with Lyl1 +/− mice having an intermediate frequency and absolute number, suggestive of dependence on the 'dose' of Lyl1.
Because LMPPs give rise to both common lympoid progenitors (CLPs) and ETPs, we also quantified these progenitor cells. We observed a significantly lower frequency and total number of CLPs (Supplementary Fig. 1 ), ETPs and DN2 thymocytes, as well as DN3 thymocytes, in Lyl1 +/− and Lyl1 −/− mice than in wildtype mice (Fig. 1d-f) ; this effect was dependent on the dose of Lyl1. Although the bone marrow had only moderately fewer CLPs (Lyl1 +/− , 67% as much as wild-type (P < 0.05); Lyl1 −/− , 57% as much as wild-type (P < 0.01; Supplementary Fig. 1)) , in the thymus, we observed considerably fewer ETPs (6% as much as wild-type (P < 0.001)) and an almost complete loss of DN2 thymocytes (1% as much as wild-type (P < 0.001)). Additional analysis showed no difference between Lyl1 −/− and wild-type mice in erythromyeloid progenitors (common myeloid progenitors, granulocytemacrophage progenitors and megakaryocytic-erythroid progenitors; Supplementary Fig. 1 ). These observations demonstrated that Lyl-1 was required in a gene dose-dependent manner for the generation of LMPPs, CLPs and ETPs.
Lyl-1 promotes the survival of ETPs and DN2 thymocytes Because LYL1 has oncogenic potential 21 and overexpression of Lyl1 in mouse bone marrow results in more proliferation and restrained apoptosis 22 , we assessed whether Lyl-1 was required for the survival and/or population expansion of multipotent progenitor cells. Analysis of the incorporation of the thymidine analog BrdU into bone marrow and thymic subpopulations showed more such incorporation in all Lyl1 −/− bone marrow subsets examined (HSCs, LMPPs and MPPs) than in their wild-type counterparts (Fig. 2a,b) . In contrast, Lyl1 −/− thymocyte subsets (ETPs and DN2 and DN3 thymocytes) had a proliferative state similar to that of wild-type cells (Fig. 2b) .
Analysis of the binding of annexin V to in vitro cultures showed a similar frequency of apoptotic HSCs and MPPs among wild-type and Lyl1 −/− cells but a lower frequency of apoptotic cells among 
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LMPPs than among wild-type LMPPs (Fig. 2c) , which suggested that at the LMPP stage, Lyl-1 did not control cell death. However, annexin V staining was significantly higher in the Lyl1 −/− ETP and DN2 subpopulations than in the corresponding wild-type subpopulations (Fig. 2d,e and Supplementary Fig. 2 ). These observations indicated that the lower abundance of LMPPs in Lyl1 −/− mice was not a consequence of restricted proliferation or more cell death of the LMPPs or their precursors. Instead, the almost complete loss of ETPs and DN2s in Lyl1 −/− mice can be attributed at least in part to a role for Lyl-1 in the survival of these cells.
Impaired T cell development of Lyl-1-deficient LMPPs
Our observations, together with published data 15, 17 , indicated the importance of Lyl-1 for the lymphoid priming of multipotent progenitor cells. The considerably lower abundance of T cell progenitors in the absence of Lyl-1 led us to asssess its involvement in lineage specification. We compared the erythro-myeloid differentiation potential of single wild-type and Lyl1 −/− LMPPs by methylcellulose assay. Lyl1 −/− LMPPs generated larger and significantly more colonies than wild-type LMPPs did (Fig. 3a) . In these conditions, LMPPs of either genotype generated exclusively colony-forming units that produced granulocytes, macrophages, or granulocytes and macrophages (Fig. 3a) . Flow cytometry confirmed their restriction from the megakaryocyte-erythroid lineage by the absence of megakaryocytes (Fig. 3b) .
We compared the potential of wild-type and Lyl1 −/− LMPPs to differentiate into B cells and T cells on OP9 mouse bone marrow stromal cells engineered to express green fluorescent protein (OP9-GFP cells) and OP9 cells that express the Notch ligand DL1 (OP9-DL1 cells). On OP9-GFP cells, LMPPs of either genotype generated CD19 + B220 + B cells (Fig. 3c) . In contrast, Lyl1 −/− LMPPs showed less population expansion and delayed differentiation kinetics relative to that of wildtype cells in coculture with OP9-DL1 cells. After 14 d of culture, wild-type LMPPs had generated DN3 thymocytes, whereas very few Lyl1 −/− LMPPs had reached this stage and showed a partial developmental block at the DN1-to-DN2 transition (Fig. 3d) .
To examine the in vivo lineage potential of Lyl1 −/− LMPPs, we transplanted 5 × 10 3 wild-type or Lyl1 −/− LMPPs intravenously into sublethally irradiated wild-type recipient mice. When assessed 14 d later, LMPPs of each strain showed similar engraftment in the bone marrow and spleens of recipient mice (4-5%) and had a similar lineage output biased toward B cells (bone marrow, >90%; spleen, 68-75%) with few granulocytes or macrophages. Wild-type LMPPs showed substantial thymic engraftment (5.1%) and robust generation of CD4 + CD8 + double-positive (DP) thymocytes, whereas Lyl1 −/− LMPPs achieved only marginal thymic engraftment (0.12%) and failed to generate T cells (Fig. 3e) . These data suggested that loss of Lyl-1 did not affect the ability of LMPPs to develop into myeloid or B lymphoid cells but considerably impaired their potential to develop into T lymphocytes.
The ETP-to-DN2 cell transition requires Lyl-1 Because we observed a significantly higher proportion of apoptotic ETPs and DN2 thymocytes in Lyl1 −/− mice, and because Lyl1 −/− LMPPs were defective in their ability to differentiate and expand their populations on OP9-DL1 stromal cells, we assessed whether Lyl-1 was required for the homeostasis of thymic progenitor cells. To determine whether the observed phenotypes of Lyl-1-deficient progenitors had an effect on later developmental stages in thymopoiesis, we compared the absolute number of DP and CD4 + or CD8 + single-positive (SP) thymocytes as well as the frequency of cells of non-T cell lineages in the thymuses of Lyl1 −/− and wild-type mice. On average, Lyl1 −/− mice had fewer total cells per thymus as well as smaller DP populations (85% of the abundance in wild-type mice), whereas the CD4 + and CD8 + SP populations were unaffected. Similar to the results we obtained with OP9-DL1 cultures, we found a partial developmental block in the thymuses of Lyl1 −/− mice at the DN1-to-DN2 transition. Additionally, the frequency of myeloid (Gr-1 + Mac-1 + ) cells and natural killer (NK1.1 + ) cells was slightly higher in the thymuses of Lyl1 −/− mice than in those of wild-type mice (Supplementary Fig. 3 ). These results indicated complete restoration of T cell development in Lyl1 −/− mice after the DN3 stage, which suggested compensatory mechanisms acted in steady-state conditions in Lyl1 −/− thymopoiesis during later T cell developmental stages. 
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The selective engraftment defect observed in the thymus after intravenous transplantation of Lyl1 −/− LMPPs could have been due to defective homing of Lyl-1-deficient progenitors to the thymus. To directly assess the potential of Lyl1 −/− LMPPs to undergo differentiation into the T lineage and population expansion in the absence of homing requirements, we injected sorted LMPPs into the thymus of non-irradiated wild-type recipient mice and analyzed their T cell output. Injection of wild-type LMPPs resulted in fivefold more recovery of total donor cells than did injection of Lyl1 −/− LMPPs (Fig. 4a) . Approximately 40% of the donor cells derived from wild-type LMPPs were of the T cell lineage (DN3, DP or SP), whereas we found commitment of Lyl1 −/− cells to the T lineage in only 20% of the recovered cells. By absolute numbers, wildtype LMPPs generated 8-fold more DN3 thymocytes, 21-fold more DP thymocytes and 9-fold more SP thymocytes committed to the T lineage than did Lyl1 −/− LMPPs. In addition, fewer wild-type cells than Lyl1 −/− cells remained in the c-Kit + ETP-LMPP-like stage ( Fig. 4b-d) .
To assess the requirement for Lyl-1 in the suppression of alternative lineage fates in ETPs, we also evaluated the potential of Lyl1 −/− Lin − bone marrow cells to develop into myeloid cells, natural killer cells, T cells and B cells 3 weeks after intrathymic injection into sublethally irradiated wild-type mice. Injection of Lyl1 −/− Lin − bone marrow cells resulted in significantly less T cell engraftment than did injection of wild-type Lin − bone marrow cells (P < 0.01), but it slightly induced intrathymic myeloid development ( Supplementary Fig. 4 ). Although we also confirmed the enhanced myeloid output of Lyl1 −/− cells in vitro under conditions that promoted both myeloid and lymphoid differentiation ( Supplementary Fig. 4) , the in vivo effect was too weak to account for the almost complete loss of thymic T cell development observed in transplantation assays. Collectively, these data confirmed the findings obtained by in vitro coculture with OP9-DL1 cells by showing delayed differentiation and impaired population expansion of Lyl1 −/− LMPPs after intrathymic injection and suggested a defect in the ability of Lyl1 −/− progenitors to undergo the ETP-to-DN2 cell transition. Although a few ETPs alternatively adopted a myeloid fate, loss of Lyl-1 did not support an alternative lineage fate in the thymus.
Lyl1 restores the T lineage fate of thymic progenitors
To assess whether the defects in differentiation into the T lineage and population expansion observed in the Lyl1 −/− mice were a direct consequence of the loss of Lyl-1 in hematopoietic progenitors, we attempted to 'rescue' this phenotype through the use of retroviral vectors expressing Lyl1. We transduced bone marrow progenitor cells from Lyl1 −/− (CD45.2 + ) mice with retroviral vector expressing either GFP only (MIG-GFP) or both Lyl-1 and GFP (MIG-Lyl-1) and transplanted those cells into lethally irradiated wild-type (CD45.1 + ) recipient mice. After 4 weeks, the transduction efficiency and lineage output of the cells transduced with MIG-GFP and MIG-Lyl-1 were similar (Fig. 5a) . After 8-12 weeks, there was significantly more population expansion of MIG-Lyl-1-transduced GFP + cells than of MIG-GFP-transduced GFP + cells; this was solely attributable to the population expansion of T cells (Fig. 5a) . At 16 weeks, the T cell population expansion was saturated and accounted for 70% of the GFP + white blood cells (Fig. 5a) Lyl1 mature with a frequency of CD4 + , CD8 + and TCRβ + subpopulations similar to that of nontransplanted wild-type control mice (data not shown), which indicated enhanced but normal T cell development.
At 12 weeks, thymuses of recipients of transplanted cells expressing MIG-Lyl-1 showed significantly greater overall cellularity attributable to a significantly higher proportion of GFP + thymocytes than that of the control recipients of transplanted cells expressing MIG-GFP (Fig. 5b) . Hence, the absolute number of GFP + thymocytes was also significantly higher in recipients of cells transduced to express MIG-Lyl-1 than in recipients of cells transduced to express MIG-GFP. However, the peripheral lymphocyte and white blood cell counts of these groups were indistinguishable (Fig. 5b) . We compared the contribution of GFP + cells to the peripheral blood, bone marrow and the thymus of recipients transplanted with bone marrow progenitors transduced with MIG-Lyl-1 or MIG-GFP and found that recipients of MIG-Lyl-1-transduced progenitors had a significantly higher frequency of GFP + cells in the peripheral blood and thymus than did recipients of cells transduced with MIG-GFP; this was attributable to the enhanced thymic T cell output (Fig. 5c) . In contrast, the frequency of GFP + cells in the bone marrow was lower in the group given cells transduced to express MIG-Lyl-1 than in the control group given cells transduced to express MIG-GFP (Fig. 5c) , which suggested that overexpression of Lyl-1 did not enhance the population expansion of progenitor cells in general but specifically did so in the thymus. 
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The majority of GFP + thymocytes in both groups were DP cells (MIG-GFP, 46.2% ± 6.7%; MIG-Lyl-1, 56.8% ± 5.8%). Lyl1 −/− cells transduced to express MIG-GFP generated significantly lower proportions of CD4 + or CD8 + SP cells but a higher frequency of DN thymocytes (MIG-GFP, 39.5% ± 8.8%; MIG-Lyl-1, 10.1% ± 2.1%) than did Lyl1 −/− cells transduced to express MIG-Lyl-1 (Fig. 5d) , which confirmed the impaired T cell differentiation in the absence of Lyl-1. Although all GFP + thymocytes in the recipients of cells transduced to express MIG-GFP were c-Kit − , cells transduced to express MIGLyl-1 were c-Kit + CD25 + in most recipients (Fig. 5e,f) , which suggested that progenitor cells transduced to express Lyl-1 had undergone the ETP-to-DN2 cell transition. In retransplantation assays, GFP + thymocytes from recipients of cells transduced to express MIG-Lyl-1 or MIG-GFP did not engraft after transplantation into irradiated wildtype recipients (data not shown), which suggested that overexpression of Lyl-1 did not induce thymocyte self-renewal.
Quantitative real-time PCR analysis of Lyl1 mRNA in sorted thymocyte subsets (DN1, DN2, DN3, DN4 and DP) from Lyl1 −/− thymocytes transduced to express MIG-Lyl-1 confirmed high expression of Lyl1 at all stages of thymocyte maturation (Fig. 5g) , which suggested that superabundance of Lyl-1 was fully compatible with the T cell developmental program. In contrast, the expression of mRNA for potential heterodimerization partners of Lyl-1, such as E2A and Heb, was upregulated only moderately (Fig. 5g) . Our results demonstrated that reintroduction of Lyl1 in bone marrow progenitors promoted the T lineage fate in cells overexpressing Lyl-1 due to complete restoration of the thymic progenitor populations.
Direct regulation of Gfi1 by Lyl-1
To gain understanding of the underlying mechanisms of Lyl-1-mediated lymphoid specification, we did global gene-expression profiling of wild-type and Lyl1 −/− LMPPs. We identified 91 genes with a difference in expression of more than twofold (P < 0.05); of those, 29 genes were upregulated and 62 genes were downregulated in Lyl1 −/− LMPPs (Supplementary Table 1 ). Quantitative real-time PCR analysis of a subset confirmed those results (data not shown). To identify direct targets of Lyl-1 in LMPPs, we looked for genes with a difference in expression that contained Lyl-1-binding-signals identified before in mouse HPC-7 hematopoietic progenitor cells by chromatin immunoprecipitation (ChIP) followed by sequencing 23 . Of the 91 genes with a difference in expression of more than twofold, 34 contained a Lyl-1-binding peak, and of those genes with a difference in expression of more than 1.6-fold, we identified 81 direct candidates (Supplementary Table 2 ). We did ChIP assays of some of those genes (Gfi1, Il15, Selp, Havcr2, Ifngr2 and Rap1a) with wild-type bone marrow enriched for cells expressing c-Kit; these assays confirmed the binding of Lyl-1 to these gene regions (Supplementary Fig. 5) .
A potential Lyl-1-binding peak at a known enhancer 35 kilobases upstream of Gfi1 (Supplementary Fig. 5 ), shown to have consistent hematopoietic activity in embryos with transgenic expression of a bacterial artificial chromosome with the gene encoding β-galactosidase inserted into the Gfi1 start site 24 , was of particular interest because Gfi-1 is known to have a role in the homeostasis of both HSCs and early thymocytes 25, 26 . ChIP assays of c-Kit + bone marrow cells showed considerable enrichment for Lyl-1 at this enhancer in wild-type cells but not in Lyl1 −/− cells (Fig. 6a) . Transactivation assays demonstrated that administration of Lyl-1 through the use of an expression plasmid, alone or together with known members of the Scl complex 27 , including E12, Lmo2 and Ldb1, increased the activity of this enhancer (Fig. 6b) , which established that Lyl-1 regulated Gfi1 expression.
To determine whether Lyl-1 promotes T cell lymphopoiesis by regulating Gfi1 expression at the LMPP and ETP stages, we did quantitative real-time PCR of Gfi1 mRNA in highly purified subsets of wild-type and Lyl1 −/− HSCs, MPPs, LMPPs, ETPs and DN1, DN2 and DN3 thymocytes. Gfi1 expression was higher in Lyl1 −/− HSCs and MPPs than wild-type HSCs and MPPs but was 50% and 13% as high in Lyl1 −/− LMPPs and ETPs, respectively, as in wild-type LMPPs and ETPs (Fig. 6c) . Consistent with those data, Gfi1 expression was also 33-50% as high in Lyl1 −/− DN1-DN3 thymocytes as in wild-type DN1-DN3 thymocytes (data not shown). In addition, Gfi1 expression was higher in thymocytes derived from recipients of Lyl1 −/− cells transduced to express MIG-Lyl-1 than recipients of Lyl1 −/− cells transduced to express MIG-GFP, at 12 weeks after transplantation (Fig. 6d) . Likewise, transduction of wild-type bone marrow progenitors to express MIG-Lyl-1 induced Gfi1 mRNA npg expression by over fourfold after 36 h of culture (Fig. 6e) , which suggested immediate induction of Gfi1 expression after boost in the dose of Lyl-1. In contrast, overexpression of Lyl1 did not induce substantial Flt3 expression (Fig. 6e) .
Lyl-1 controls thymocyte progenitors in part through Gfi1
Next we assessed whether Gfi-1 controlled T cell development downstream of Lyl-1 by overexpressing Gfi-1 in wild-type and Lyl1 −/− cells. However, when we transduced wild-type and Lyl1 −/− cells with retroviral vector expressing both Gfi-1 and GFP (MIG-Gfi-1) and transplanted those cells intravenously into wild-type recipient mice, we found that abundant expression of Gfi-1 was not compatible with lymphoid development, most probably because of immediate induction of both myeloid differentiation and loss of progenitor activity (data not shown). Therefore, we transduced Lyl1 −/− bone marrow progenitor cells to express MIG-GFP, MIG-Gfi-1 or MIG-Lyl-1 and immediately injected equal numbers of these cells intrathymically into wild-type recipient mice. Although the total number of GFP + thymocytes was unaffected, retroviral expression of Gfi-1 in Lyl1 −/− progenitors permitted lymphoid development, and we noted a trend toward a greater frequency of T lineage cells after injection of cells transduced to express MIG-Gfi-1 than after injection of control cells transduced to express MIG-GFP (P = 0.1; Supplementary Fig. 6 ); this suggested that Gfi1 was a critical target of Lyl-1 at the ETP stage, enabling thymic development of the T cell lineage. We noted more complete restoration after retroviral expression of Lyl-1 (P < 0.001; Supplementary Fig. 6 ).
We also used the OP9-DL1 coculture system to assess the ability of Gfi-1 to 'rescue' the Lyl-1 deficiency. Transduction of Lyl1 −/− cells with retrovirus expressing Gfi-1 or Lyl-1 promoted lymphocyte population expansion and generated DN3 thymocytes after 12 d of culture (Fig. 7a) . We also quantified 'rescued' cells after transduction of equal numbers of wild-type or Lyl1 −/− cells (Fig. 7b,c) . Although overexpression of Gfi-1 resulted in significantly more T cells derived from Lyl1 −/− progenitors than did overexpression of MIG-GFP, the absolute number of T cells was significantly lower than those from Lyl1 −/− cells transduced to express MIG-Lyl-1 or wild-type cells transduced to express MIG-Gfi-1 (Fig. 7b,c) . Notably, overexpression of Gfi-1 in wild-type progenitors resulted in a significantly lower absolute number of T cells than did overexpression of GFP or Lyl-1 (Fig. 7c) , which indicated a dose-limiting role for Gfi-1 in T lymphoid development. Collectively, these data supported our finding that Gfi1 acted as a key downstream target of Lyl-1 mediating T cell development. Because some of our data suggested a role for Lyl-1 in protection from cell death (Fig. 2) , we also determined whether retroviral overexpression of the prosurvival factor Bcl-2 would 'rescue' the Lyl1 −/− T lineage phenotype. In transplantation assays and OP9-DL1 cocultures, Bcl-2 promoted the development and population expansion of T cells, but flow cytometry of thymocytes in vivo showed that Bcl-2 did not overcome the DN2 progression defect (Supplementary Fig. 7 ).
DISCUSSION
In this study we have shown that Lyl-1 was a crucial participant in the transcriptional network that regulates the lymphoid specification of multipotent bone marrow progenitors and the maintenance of uncommitted T cell progenitors. Our data suggested that Lyl-1 gained control of the survival and population expansion of thymic progenitors during critical stages of the population expansion of pro-T cells. Loss of Lyl-1 in the hematopoietic system diminished the ability to generate LMPPs, which most probably accounts for the profound deficiency in lymphoid engraftment seen after transplantation of Lyl1 −/− bone marrow cells 15, 17 . However, unlike the loss of PU. 1 (refs. 7,9,19) or Ikaros 11, 17 , ablation of Lyl1 still permitted the generation of LMPPs, although in lower abundance. Consistent with that, we observed relatively mild changes in gene expression in Lyl-1-deficient LMPPs.
Such characteristics are reminiscent of LMPPs after loss of the gene encoding the transcription factor E2A 8 ; both Lyl-1 and E2A regulate the LMPP population in a dose-dependent manner, and loss of either is associated with less apoptosis of LMPPs and a greater abundance of Bcl2 mRNA 8 . As Lyl-1 and E2A are basic helix-loop-helix transcription factors that form heterodimers in bone marrow progenitor cells 28 , they may interact during lymphoid priming of MPPs to regulate a set of common target genes. However, several known E2A targets 10, 29, 30 (such as Rag1, Dntt, Notch1 and Notch3) do not have different expression in Lyl1 −/− LMPPs 31, 32 , which indicates that the relationships between Lyl-1 and E-proteins change during hematopoietic development 31, 32 . Accordingly, loss of E2A, in contrast to loss of Lyl-1, results only in mild HSC defects, which suggests that Lyl-1-E2A interactions are not critical in HSCs 14, 15, 33 . Similarly, during lymphoid differentiation, the genes encoding Ikaros, PU.1 and Gfi-1 are not dependent on E2A for their expression, which indicates distinct roles for Lyl-1 and E2A in early thymocyte progenitors 8, 34 . Fully delineating these dynamic relationships will require further analysis.
Our data indicating that Lyl-1 was critical in the maintenance of thymopoiesis raises the question of how loss of Lyl-1 negatively affects ETP development. Because ETP numbers are correlated with npg A r t i c l e s LMPP numbers 35 , a simple explanation for this could be of the lower number of LMPPs or a requirement for Lyl-1 for homing to the thymus. However, our data have demonstrated a key role for Lyl-1 after entry into the thymus in part through activation of Gfi1. The overlap of phenotypes observed after loss of either Gfi-1 or Lyl-1 (fewer Flt3 hi LSK cells as well as lymphoid engraftment defects) supports such a conclusion 25, 26 . Moreover, T cell development in mice deficient in Gfi-1 or Lyl-1 is considerably impaired because of more apoptosis of c-Kit + thymocyte progenitors 26, 35 . Nevertheless, Lyl1 −/− HSCs and MPPs had normal Gfi1 expression and lacked the defects noted in Gfi1 −/− mice 15, 17 , which establishes that Lyl-1 is not essential for Gfi1 expression before the LMPP stage. Therefore, control of Gfi1 expression in different progenitor populations is probably mediated by multiple transcription factors in addition to Lyl-1 in a contextdependent manner. Notably, Scl has also been identified (by ChIP followed by sequencing) as binding to the enhancer element 35 kilobases upstream of Gfi1 (ref. 24) . In bone marrow HSCs, Scl and Lyl-1 act redundantly to enable HSC survival 14 and may be interchangeable in terms of regulating Gfi1 expression. The downregulation of Scl earlier than the downregulation of Lyl-1 during thymocyte development may explain the specific sensitivity of progenitors of T cells to the loss of Lyl-1 and the nonredundant function of Lyl-1. Other regulators, such as PU.1 and GATA-2, that control Gfi1 during myeloid development were also not able to compensate for Lyl-1 loss at the LMPP-ETP stage. Collectively, these findings support a model in which Lyl-1 becomes increasingly important in lymphoid progenitor development and finally becomes indispensable at the ETP-DN2 stage to maintain the survival and homeostasis of progenitors of T cells via Gfi-1.
The proliferation and survival of ETPs is also highly dependent on Bcl2 expression mediated by IL-7 and its receptor (IL-7R) and the Jak kinase and STAT transcription factor signaling pathway 36, 37 . During B cell development, Gfi-1 modulates signaling via IL-7R through SOCS3, a negative regulator of Jak, as well as through direct regulation of IL-7R expression 38 . Therefore, it is possible that, similar to its control of B cell development, Lyl-1 controls the survival of early thymocytes through Gfi-1-dependent regulation of IL-7-IL-7R signaling. This would explain our findings that overexpression of either Gfi1 or Bcl2 partially 'rescued' Lyl1 −/− T cells.
Since its initial description in human T cell acute lymphoblastic leukemia, Lyl-1 has been linked to hematological transformation, but the underlying mechanisms of this have remained elusive. Because loss of E2A leads to T cell lymphomas 39 , overexpression of Scl and Lyl-1 have been assumed to effect transformation mainly by disrupting E2A homodimers 40 . However, our results have indicated a distinct mechanism for the involvement of Lyl-1 in T cell acute lymphoblastic leukemia, via control of the T-progenitor pool. The finding that superabundant amounts of Lyl-1 were fully compatible with T cell development also refuted the competitive inhibition model. The involvement of Lyl-1 in the expression of Gfi1 and Rap1a suggests a previously unknown potential mechanism for Lyl-1-mediated malignant transformation. Activation of the GTPase Rap1α promotes thymocyte proliferation and transformation 41 , whereas Gfi-1 inhibits apoptosis 42 and enhances entry into the cell cycle 43 . These data suggest that Lyl-1 contributes to transformation via the deregulation of critical target genes rather than through the disruption of E-protein function.
Collectively, our data have demonstrated that the population expansion and survival of pro-T cells is regulated through intrinsic control of thymic progenitors that use a transcriptional program already established in hematopoietic stem and progenitor cells. Lyl-1 is a critical component of this regulatory network, vital for the maintenance of T lineage homeostasis. The identification of downstream mediators of Lyl-1 function elucidates molecular mechanisms that underlie early T cell development and suggests that previously unrecognized pathways probably have a role in Lyl-1-mediated development of leukemia and lymphoma.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: microarray data, GSE38681.
ONLINE METHODS
Mice. Transgenic mice (C57BL/6 Lyl1-Mg 15 ) were bred and maintained in pathogen-free conditions in the animal facility at Baylor College of Medicine. C57BL/6 CD45.1 + and CD45.2 + congenic mice were used for tracking of donor and recipient cells. All mice were 8-10 weeks of age at the time of analysis. Housing, breeding and experimental use of animals was according to Institutional Animal Care and Use Committee guidelines.
Antibodies. All antibodies are described in Supplementary Table 3. Flow cytometry, cell sorting and population definitions. Single-cell suspensions were prepared from spleen, thymus and bone marrow (femoral and tibial bone) by passage through a 70-µm cell strainer (Fischer Scientific). Blood was obtained by retro-orbital puncture after treatment of mice with isoflourane. Cells were resuspended in Hank's balanced-salt solution containing 2% FBS. For progenitor analysis cells were stained on ice for 20 min with the following fluorochrome-conjugated antibodies: for ETPs and DN2-DN3 cells (thymus), antibodies to lineage markers (CD3ε, CD8α, TCRβ, TCRγδ, NK1.1, CD11c, Ter119, CD11b, Ly-6G, B220 and CD19), anti-c-Kit and anti-CD25; for HSCs, MPPs, LMPPs and CLPs (bone marrow): antibodies to lineage markers (CD3ε, CD4, CD8α, NK1.1, Ter119, CD11b, Ly-6G, B220), anti-c-Kit, anti-Sca-1, antiFlt3, anti-IL-7Rα; for common myeloid progenitors, megakaryocytic-erythroid progenitors and granulocyte-macrophage progenitors (bone marrow): antibodies to lineage markers (CD3ε, CD4, CD8α, NK1.1, Ter119, CD11b, Ly-6G, B220, CD19 and IgM), anti-IL-7Rα, anti-c-Kit, anti-Sca-1, anti-FcγRII-III and anti-CD34. After being stained, cells were washed and resuspended in Hank's balanced-salt solution containing 2% FBS and propidium iodide for the exclusion of dead cells.
For sorting, cells were first stained with biotin-conjugated antibodies to lineage markers and then samples were depleted of those cells with an auto-MACS and streptavidin-conjugated MicroBeads (Miltenyi Biotec). Gating strategies have been described 44 Determination of progenitor population size. The absolute number of viable cells of bone marrow (two tibias and two femurs) and thymuses were determined by Trypan blue exclusion. For analysis of the absolute number of progenitors in each mouse, this number was multiplied by the percent of each sub-gate in the viable cell gate (propidium iodide negative). For minimization of the difference in cell numbers caused by animal size, the number of bone marrow progenitors was further normalized to 50 × 10 6 total bone marrow cells.
Real-time PCR. Total RNA was extracted with RNAqueous from populations sorted by flow cytometry and was treated with DNaseI (Invitrogen). Then, RNA was reverse-transcribed with SuperScript III (Invitrogen) and random hexamer primers. The input cDNA was standardized and then amplified for 40 cycles on an ABI Prism 7900HT (Applied Biosystems) with Taqman Master Mix (Applied Biosystems), 18S rRNA probe (VIC-MGB; Applied Biosystems) and gene-specific probes (FAM-MGB; Applied Biosystems) or SYBR Green Master Mix (Applied Biosystems), primers for Gapdh (encoding glyceraldehyde phosphate dehydrogenase) and gene-specific primers (all PCR primers, Supplementary Table 4) . Samples were analyzed in triplicate and results were normalized to those of 18S rRNA or GAP-DH. Change in expression was determined by the change-in-cycling-threshold (∆∆C T ) method.
In vitro methylcellulose colony-forming cell assay. For the multilineage assay of colony-forming units that generate granulocytes, monocytes, granulocytesmonocytes and granulocytes-erythrocytes-monocytes-megakarocytes, single LMPPs from Lyl1 +/+ and Lyl1 −/− mice were sorted into 96-well plates containing Methocult M3434 supplemented with recombinant human erythropoietin, recombinant mouse IL-3, recombinant human IL-6 and recombinant mouse stem cell factor (StemCell Technologies) and were incubated for 12 d at 37 °C with 5% CO 2 and >95% humidity. Colonies were screened at day 9 for burstforming units that produced erythroid cells and were analyzed at day 12 of culture with an inverted microscope (Olympus IX70) according to published criteria 46 . The identity and proportions of cell types represented in individually picked multilineage colonies was confirmed by flow cytometry (megakaryocyte (CD41 + ), granulocyte (Mac-1 + Gr1 + F4/80 − ) macrophage (Mac-1 + F4/80 + ) and monocytes (Mac-1 + Gr-1 − F4/80 − ).
In vitro differentiation assay. OP9-GFP and OP9-DL1 cells were maintained and cultured as described 47 . Sorted LMPPs (2.5 × 10 2 per well) or transduced Sca-1 + progenitors (5 × 10 5 per well) from Lyl1 +/+ and Lyl1 −/− mice were cultured for 12 or 14 d on OP9-GFP or OP9-DL1 cells in the presence of recombinant mouse ligand for Flt3 (20 ng/ml) and recombinant mouse IL-7 (20 ng/ml). In addition, LMPPs were also cultured without stromal support in Iscove's modified Dulbecco's medium supplemented with recombinant mouse IL-7 (20 ng/ml), recombinant mouse ligand for Flt3 (100 ng/ml) and recombinant mouse stem cell factor (50 ng/ml; Peprotech). After incubation, cells were stained for markers specific for myeloid cells, B cells and T cells and were analyzed with an LSR II.
LMPP transplantation. CD45.2 + Lyl1 +/+ and Lyl1 −/− LMPPs were sorted and transplanted by retroorbital injection into sublethally irradiated (one dose of 5.25 Gy) recipient mice (5 × 10 3 cells per recipient). At day 14 after transplantation, bone marrow, spleen and thymus were collected and analyzed by flow cytometry for donor output. Thymuses were depleted of CD45.1 + host cells before staining.
Intrathymic injection. CD45.2 + Lyl1 +/+ and Lyl1 −/− LMPPs were sorted and transplanted by intrathymic injection into nonirradiated recipient mice (1 × 10 4 cells per recipient) as described 48 . Thymuses were collected at day 9 after injection and analyzed by flow cytometry for T cell linage output.
Engraftment analysis. T cell output was analyzed in the thymus, so thymocyte samples were first depleted of host cells by autoMACS with streptavidinconjugated MicroBeads (Miltenyi Biotec) and biotin-conjugated anti-CD45.1. After depletion, thymocytes were stained and all remaining cells were analyzed by flow cytometry. Spleens and bone marrow were collected, processed into single-cell suspensions and treated with NH 4 Cl lysis buffer (nine parts 0.16 M NH 4 Cl plus one part 0.17 M Tris, pH 7.65) for removal of red blood cells before being stained with myeloid-and B cell-specific fluorochrome-conjugated antibodies. Chimerism of the bone marrow, spleen and thymus is presented as the frequency of CD45.2 + cells in the viable cell gate (propidium iodide negative). All other results are presented as the frequency of donor cells.
Retroviral transduction of bone marrow cells. Retroviral transduction of bone marrow cells has been described 22 . C57BL/6-CD45.2 Lyl1 −/− and Lyl1 +/+ mice were treated with 5-fluoruracil, then progenitor cells from those mice were enriched for Sca-1 + cells and then transduced to express MIG-GFP, MIG-Bcl-2 or MIG-Lyl-1 (the last two plasmids contained wildtype mouse Bcl2 or Lyl1) and transplanted into lethally irradiated recipients (10.5 Gy in two doses) or were cultured in Stempro34 media (Invitrogen). For real-time PCR analysis, cells were cultured for 36 h, then GFP-expressing cells were sorted and RNA prepared for rt-PCR. For transplant experiments, mice were maintained for 4-16 weeks (as indicated in figures), then were killed for flow cytometry analysis of the peripheral blood, bone marrow and thymus. In addition, complete blood counts were done with Hemavet HV959FS. 
